Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Role of gonadotropin-releasing hormone agonists, human chorionic gonadotropin (hCG), progesterone, and estrogen in luteal phase support after hCG triggering, and when in pregnancy hormonal support can be stopped

Research output: Contribution to journalReviewResearchpeer-review

  1. Psychological stress, stressful life events, male factor infertility, and testicular function: a cross-sectional study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Therapeutic endometrial scratching and implantation after in vitro fertilization: a multicenter randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Associations of different molecular forms of antimüllerian hormone and biomarkers of polycystic ovary syndrome and normal women

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Review of injection techniques for spermatogonial stem cell transplantation

    Research output: Contribution to journalReviewResearchpeer-review

  2. Ovarian cortical follicle density in infertile women with low anti-Müllerian hormone

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gene Expression in Granulosa Cells From Small Antral Follicles From Women With or Without Polycystic Ovaries

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Luteal phase support is mandatory in ovarian stimulation cycles in assisted reproductive technology owing to a deficit in LH pulsatility after the effects of exogenous hCG-used for triggering ovulation-vanish. This is classically accomplished by means of exogenous P administration, but emerging new options include microdoses of hCG and exogenous GnRH agonist. Although luteal phase support is commonly continued for up to 10 weeks into pregnancy, there is accumulating evidence that it can be stopped after the first ultrasound or even after a positive pregnancy test.

Original languageEnglish
JournalFertility and Sterility
Volume109
Issue number5
Pages (from-to)749-755
Number of pages7
ISSN0015-0282
DOIs
Publication statusPublished - 1 May 2018

ID: 54944815